Essity reported Q4 19 organic growth of 3.6% with consumer tissue leading with +4.9%. Regionally, emerging markets delivered another strong quarter (+6.6%). Adjusted EBITA came in at SEK 4.7bn (margin 14.1%). The company proposed a final dividend of SEK 6.25/share. On the cautious side, the company announced price cuts in consumer tissue Europe, effective Q1 20. However, we do not expect significant margin pressure and foresee no meaningful change in our estimates or target price.
27 Jan 2020
Price cut fears overshadow good Q4.
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Price cut fears overshadow good Q4.
Essity AB Class A (ESSITY.A:OME) | 0 0 0.0%
- Published:
27 Jan 2020 -
Author:
Virendra Chauhan -
Pages:
4
Essity reported Q4 19 organic growth of 3.6% with consumer tissue leading with +4.9%. Regionally, emerging markets delivered another strong quarter (+6.6%). Adjusted EBITA came in at SEK 4.7bn (margin 14.1%). The company proposed a final dividend of SEK 6.25/share. On the cautious side, the company announced price cuts in consumer tissue Europe, effective Q1 20. However, we do not expect significant margin pressure and foresee no meaningful change in our estimates or target price.